Lessons from chronic renal diseases in African Americans: Treatment implications

Ethnicity and Disease

Volumn 13, Issue 2 SUPPL. 2, 2003, Pages

  Agodoa, Lawrence ^a  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

African American; Renal disease

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ILLICIT DRUG;

ADULT; AGED; ARTICLE; ASIAN; BLOOD PRESSURE REGULATION; CAUCASIAN; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; DEVELOPED COUNTRY; DEVELOPING COUNTRY; DISEASE SEVERITY; DRUG ABUSE; DRUG EFFICACY; ETHNIC DIFFERENCE; ETHNIC GROUP; FEMALE; HEALTH CARE; HUMAN; INCIDENCE; KIDNEY FAILURE; LIFESTYLE; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PREVALENCE; PUBLIC HEALTH; RACE DIFFERENCE; RENOVASCULAR DISEASE; RENOVASCULAR HYPERTENSION; SOCIAL STATUS; UNITED STATES; ADDICTION; AFRICAN AMERICAN; CHRONIC KIDNEY FAILURE; CLASSIFICATION; COMPARATIVE STUDY; DIABETES MELLITUS; ETHNOLOGY; HEALTH CARE DELIVERY; HYPERTENSION; KIDNEY TRANSPLANTATION; MORTALITY; RENAL REPLACEMENT THERAPY; SOCIAL CLASS; STANDARD; STATISTICS; SURVIVAL RATE; UTILIZATION REVIEW;

AFRICAN AMERICANS; ANTIHYPERTENSIVE AGENTS; DELIVERY OF HEALTH CARE; DIABETES COMPLICATIONS; DIABETES MELLITUS; ETHNIC GROUPS; HUMANS; HYPERTENSION; HYPERTENSION, RENAL; INCIDENCE; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; LIFE STYLE; PREVALENCE; RENAL DIALYSIS; SOCIAL CLASS; SUBSTANCE-RELATED DISORDERS; SURVIVAL RATE; UNITED STATES;

EID: 1542709427     PISSN: 1049510X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. US Renal Data System. USRDS 2002 Annual Data Report. Bethesda, Md: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 2002.
2. Harris MI, Flegal KM, Cowie CC, et al. Prevalence of diabetes, impaired fasting glucose and impaired glucose tolerance in US adults. The Third National Health and Nutrition Examination Survey, 1988-1994. Diabetes Care. 1998;21(4):518-524.
3. National Diabetes fact sheet: incidence of diabetes. Available at: http://www.cdc.gov/diabetes/pubs/facts98.htm#incidence
4. Klag MJ, Stamler J, Brancati FL, Neaton JD, Randall BL, Whelton PK. End-stage renal disease in African-American and White men: 16-year MRFIT findings. JAMA. 1997; 277(16):1293-1298.
5. Coresh J, Wei GL, McQuillan G, et al. Prevalence of high blood pressure and elevated serum creatinine level in the United States: findings from the Third National Health and Nutrition Examination Survey (1988-1994). Arch Intern Med. 2001;161:1207-1216.
6. Burt VL, Whelton P, Roccella EJ, Brown C, et al. Prevalence of hypertension in the US adult population. Results from the Third National Health and Nutrition Examination Survey, 1988-1991. Hypertension. 1995;3: 305-313.
7. Breslow NE, Day NE. Statistical Methods in Cancer Research. Vol 2. Lyon: IARC; 1987.
8. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Soc. 1972;53:457-481.
9. Cox D. Regression models and life tables. J R Stat Soc. 1972;34:187-201.
10. US Renal Data System. USRDS 2001 Annual Data Report. Bethesda, Md: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 2001.
11. Parving HH, Lehnert H, Brochner-Mortensen J, Gomis R, Andersen S, Arner P. The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes. N Engl J Med. 2001;345:870-878.
12. Lewis EJ, Hunsicker LG, Clarke WR, et al. Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. N Engl J Med. 2001;345:851-860.
13. Brenner BM, Cooper ME, de Zeeuw D, et al. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med. 2001; 345:861-869.
14. Fogo A, Breyer JA, Smith MC, et al, and the AASK Pilot Study Investigators. Accuracy of the diagnosis of hypertensive nephrosclerosis in African Americans: a report from the African-American Study of Kidney Diseases (AASK) Trial. Kidney Int. 1997;51:244-252.
15. Fogo A, Breyer JA, Smith MC, et al, and the AASK Pilot Study Investigators. Renal histopathology in US African Americans with presumed hypertensive nephrosclerosis. Nephrology. 1998;4:S54-S58.
16. Perneger TV, Whelton PK, Klag MJ. Risk of kidney failure associated with the use of acetaminophen, aspirin, and nonsteroidal anti-inflammatory drugs. N Engl J Med. 1994;331: 1675-1679.
17. Sandler DP, Smith JC, Weinberg CR, et al. Analgesic use and chronic renal disease. N Engl J Med. 1989;320:1238-1243.
18. Norris KC, Thornhill-Joynes M, Robinson C, Strickland T, et al. Cocaine use, hypertension, and end-stage renal disease. Am J Kidney Dis. 2001;38(3):523-528.
19. Norris KC, Thornhill-Joynes M, Tareen N. Cocaine use and chronic renal failure. Semin Nephrol. 2001;21(4):362-366.
20. Drizd T, Dannenberg AL, Engel A. Blood pressure levels in persons 18-74 years old in 1976-80, and trends in blood pressure from 1960 to 1980 in the United States. Vital Health Stat. 1986;234:10-18.
21. The Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Bethesda, Md: National Institutes of Health, National Heart, Lung, and Blood Institute; November 1997.
22. Wright JT Jr, Kusek JW, Toto RD, et al. Design and baseline characteristics of participants in the African-American Study of Kidney Disease and Hypertension (AASK) Pilot Study. Control Clin Trials. 1996;17:3S-16S.
23. Agodoa LY, Appel L, Bakris GL, et al, for the African-American Study of Kidney Disease and Hypertension (AASK) Study Group. Effect of ramipril vs amlodipine on renal outcomes in hypertensive nephrosclerosis. a randomized controlled trial. JAMA. 2001;285: 2719-2728.
24. Wright JT Jr, Bakris G, Greene T, Agodoa LY, et al, for the African-American Study of Kidney Disease and Hypertension Study Group. Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results of the AASK Trial. JAMA. 2001;288:2421-2431.
25. Winston JS, Burns GC, Klotman PE. The human immunodeficiency virus (HIV) epidemic and HIV-associated nephropathy. Semin Nephrol. 1998;18(4):373-377.